Traditional Chinese medicine for treating qi deficiency and blood stasis caused after coronary artery bypass grafting

Abstract

The invention relates to traditional Chinese medicine for treating qi deficiency and blood stasis caused after coronary artery bypass grafting. The traditional Chinese medicine can effectively solve the pharmacy problem on treatment of qi deficiency and blood stasis caused after coronary artery bypass grafting. According to the technical scheme, the traditional Chinese medicine is prepared by following raw materials including, by weight, 20 g to 30 g of codonopsis pilosula, 30 g to 40 g of astragalus membranaceus, 15 g to 20 g of rhizoma atractylodis macrocephalae, 15 g to 20 g of poria cocos, 15 g to 20 g of salvia miltiorrhiza, 3 g to 6 g of sandalwood, 3 g to 6 g of fructus amomi, 12 g to 15 g of earthworms, 10 g to 15 g of garden balsam, 5 g to 10 g of stir-baked squama manitis, 20 g to 30 g of ark shell, 12 g to 15 g of fructus trichosanthis, 10 g to 15 g of allium macrostemon and 8 g to 12 g of cassia twigs. The traditional Chinese medicine has the advantages that the effects of tonifying qi and the spleen, activating the blood, removing blood stasis, activating yang and removing stasis are achieved, complications such as saphenous vein bypass graft acute blocking, acute myocardial infarction and congestive heart failure are effectively reduced, recovery of a patient is facilitated, the death rate is reduced, and the traditional Chinese medicine is the innovation for treating qi deficiency and blood stasis caused after coronary artery bypass grafting.

Description

technical field [0001] The invention relates to medicine, in particular to a traditional Chinese medicine for treating qi deficiency and blood stasis syndrome after coronary artery bypass surgery. Background technique [0002] After coronary artery bypass grafting, patients may experience chest tightness, chest pain, palpitations, fatigue, sweating, and lack of energy, and sometimes acute occlusion of the graft vessel and acute myocardial infarction. Although conventional Western medicine antiplatelet and anticoagulant treatments are used after the operation, the above situation cannot be completely avoided, and may even lead to the death of the patient and increase the mortality rate of the patient. In addition, antiplatelet and anticoagulant drugs such as aspirin and heparin have a relatively high chance of side effects, such as gastrointestinal bleeding; sometimes patients are resistant to drugs, which can lead to ineffective or reduced efficacy of treatment, and acute o...

AI Technical Summary

Problems solved by technology

Although conventional Western medicine antiplatelet and anticoagulant treatments are used after the operation, the above situation cannot be completely avoided, and may even lead to the death of the patient and increase the mortality rate of the patient.

In addition, antiplatelet and anticoagulant drugs such as aspirin and heparin have a relatively high chance of side effects, such as gastrointestinal bleeding; sometimes patients are resistant to drugs, which can lead to ineffective or reduced efficacy of treatment, and acute occlusion of graft vessels or acute myocardial infarction.